To understand the biological significance of this interaction in the context of Alzheimer’s disease, we leveraged existing ROSMAP dorsolateral prefrontal cortex (DLPFC) transcriptomic and genetic datasets and investigated whether the interactions between CD33 and PTPN6 gene expression influence AD clinical and pathological traits. This evidence concerns the gene PTPN6 and early-onset autosomal dominant Alzheimer disease.